Risk factors and long-term prognostic impact of immune related pancreatic injury in patients receiving immune checkpoint inhibitors
BackgroundWith the widespread use of immune checkpoint inhibitors (ICIs), the management of immune-related adverse events (irAEs) has become increasingly important. ICI-induced pancreatic injury (ICI-PI) is rare, and its clinical characteristics remain…